Relationship between Circulating BAFF Serum Levels with Proliferating Markers in Patients with Multiple Myeloma

Table 1

Mean ± SD values of B-cell activating factor (BAFF), interleukin-6, -10, and -15 (IL-6, -10, and -15), C-reactive protein (CRP), beta-2 microglobulin (B2M), and Ki-67 proliferation index (Ki-67 PI) in multiple myeloma patients and controls (𝑃<0.001 in all cases).

	Controls	Patients
BAFF (pg/mL)	253.4 ± 171.9	904.2 ± 569.0
IL-6 (pg/mL)	1.0 ± 0.5	8.8 ± 7.8
IL-10 (pg/mL)	103.6 ± 16.8	170.4 ± 72.5
IL-15 (pg/mL)	5.6 ± 0.9	9.5 ± 4.7
CRR (mg/dL)	0.48 ± 0.23	1.02 ± 0.59
B2M (mg/L)	1.9 ± 0.56	3.75 ± 3.15
Ki-67 PI (%)	0.9 ± 0.9	9.3 ± 10.4